|
[1] ENGIN A. The definition and prevalence of obesity and metabolic syndrome[J]. Adv Exp Med Biol,2017,960:1-17.
|
|
[2] ANSARIMOGHADDAM A,ADINEH HA,ZAREBAN I,et al.Prevalence of metabolic syndrome in Middle-East countries:Meta-analysis of cross-sectional studies[J]. Diabetes Metab Syndr,2018,12(2):195-201.
|
|
[3] CHENG YA,TAN SY,LI M,et al. Relationship between reflux esophagitis and related factors of metabolic syndrome[J].China Med Herald,2019,16(10):92-95.(in Chinese)程怡安，谭诗云，李明，等．反流性食管炎与代谢综合征相关因素的关系[J]．中国医药导报，2019,16(10):92-95.
|
|
[4] HE Q,ZHANG H,LYU D,et al. Study on the correlation between components of metabolic syndrome and colorectal villous adenoma[J]. J Clin Exp Med,2019,18(5):519-521.(in Chinese)何强，张辉，吕栋，等．代谢综合征相关组分与结直肠绒毛状腺瘤相关性研究[J]．临床和实验医学杂志，2019,18(5):519-521.
|
|
[5] GLASS CK,WITZTUM JL. Atherosclerosis the road ahead[J].Cel,2001,104(4):503-516.
|
|
[6] SU PY,HSU YC,CHENG YF,et al. Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years[J]. BMC Gastroenterol,2019,19(1):117.
|
|
[7] YANG SD,FANG DL,ZHU ZF. Correlation analysis of metabolic syndrome and calculous cholecystitis[J]. J Clin Surg,2014,27(6):417-418.(in Chinese)杨树鼎，方东临，朱政峰．代谢综合征与胆囊结石症状发生的相关性分析[J]．临床外科杂志，2014,27(6):417-418.
|
|
[8] STENDER S,NORDESTGAARD BG,TYBJAERG-HANSEN A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease:A Mendelian randomization study[J]. Hepatology,2013,58(6):2133-2141.
|
|
[9] CHEN Z. Research advances in the diagnosis and treatment of acute cholecystitis in pregnancy and childbirth[J]. Chin J Curr Adv Gen Surg,2018,21(3):242-245.(in Chinese)陈政．孕产期合并急性胆囊炎的诊断与治疗进展[J]．中国现代普通外科进展，2018,21(3):242-245.
|
|
[10] HAN XY,XUE RQ,XIA YJ,et al. Progress of research on animal model of biliary calculi[J/CD]. Chin J Injury Repair and Wound Healing(Electronic Edition),2017,12(6):470-472.(in Chinese)韩晓月，薛荣泉，夏医君，等．胆道结石动物模型的研究进展[J/CD]．中华损伤与修复杂志(电子版)，2017,12(6):470-472.
|
|
[11] LEI ZM,YE MX,FU WG,et al. Levels of serum leptin,cholecystokinin,plasma lipid and lipoprotein differ between patients with gallstone or/and those with hepatolithiasis[J]. Hepatobiliary Pancreat Dis Int,2008,7(1):65-69.
|
|
[12] XI LF,XUE RQ,XIA YJ,et al. Function of leptin in gallstone formation[J]. Int J Surg,2017,44(6):383-387.(in Chinese)希龙夫，薛荣泉，夏医君，等．瘦素在胆囊胆固醇结石形成中的作用[J]．国际外科学杂志，2017,44(6):383-387.
|
|
[13] GREENBERG AS,OBIN MS. Obesity and the role of adipose tissue in inflammation and metabolism[J]. Am J Clin Nutr,2006,83(2):461s-465s.
|
|
[14] JONAS E,MARSK R,RASMUSSEN F,et al. Incidence of postoperative gallstone disease after antiobesity surgery:Population-based study from Sweden[J]. Surg Obes Relat Dis,2010,6(1):54-58.
|
|
[15] GUSTAFSSON U,BENTHIN L,GRANSTROM L,et al. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery[J]. Hepatology,2005,41(6):1322-1328.
|
|
[16] STOKES CS,GLUUD LL,CASPER M,et al. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss:A meta-analysis of randomized controlled trials[J].Clin Gastroenterol Hepatol,2014,12(7):1090-1100,e61.
|
|
[17] CHEN JH,TSAI MS,CHEN CY,et al. Bariatric surgery did not increase the risk of gallstone disease in obese patients:A comprehensive cohort study[J]. Obes Surg,2019,29(2):464-473.
|
|
[18] SARAC S,ATAMER A,ATAMER Y,et al. Leptin levels and lipoprotein profiles in patients with cholelithiasis[J]. J Int Med Res,2015,43(3):385-392.
|
|
[19] SUN MM,CAO LY,SUN WD,et al. Association of serum high-density lipoprotein cholesterol with new-onset cholelithiasis[J]. J Clin Hepatol,2019,35(8):1745-1750.(in Chinese)孙苗苗，曹立瀛，孙卫东，等．血清高密度脂蛋白胆固醇与新发胆石症的关系[J]．临床肝胆病杂志，2019,35(8):1745-1750.
|
|
[20] GELLERT-KRISTENSEN H,DALILAN,FALLGAARD NS,et al.Identification and replication of six loci associated with gallstone disease[J]. Hepatology,2019,70(2):597-609.
|
|
[21] GU TH. Study of bile composition and causes of gallstone in242 cases of biliary surgery[J]. J North Sichuan Med Col,2016,31(6):838-840.(in Chinese)辜天慧．242例胆道手术患者胆汁成分与胆石成因研究[J]．川北医学院学报，2016,31(6):838-840.
|
|
[22] BANKS WA,FARR SA,SALAMEH TS,et al. Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance[J]. Int J Obes(Lond),2018,42(3):391-397.
|
|
[23] SMELT AH. Triglycerides and gallstone formation[J]. Clin Chim Acta,2010,411(21-22):1625-1631.
|
|
[24] MVONDO MA,NJAMEN D,KRETZSCHMAR G,et al. Alpinumisoflavone and abyssinone V 4'-methylether derived from Erythrina lysistemon(Fabaceae)promote HDL-cholesterol synthesis and prevent cholesterol gallstone formation in ovariectomized rats[J]. J Pharm Pharmacol,2015,67(7):990-996.
|
|
[25] YAN HJ,CUI NQ,ZHANG SK,et al. Research advances in the association between abnormal lipid metabolism and cholesterol stones[J]. Chin J Surg Integr Tradit West Med,2015,21(4):419-422.(in Chinese)严豪杰，崔乃强，张淑坤，等．脂质代谢异常与胆固醇结石相关性研究进展[J]．中国中西医结合外科杂志，2015,21(4):419-422.
|
|
[26] STENDER S,FRIKKE-SCHMIDT R,BENN M,et al. Lowdensity lipoprotein cholesterol and risk of gallstone disease:A Mendelian randomization study and meta-analyses[J]. J Hepatol,2013,58(1):126-133.
|
|
[27] LIANG MY,WEI YC,WANG YM,et al. Association between fasting blood glucose and the risk of cholelithiasis[J]. J Clin Hepatol,2019,35(11):2517-2522.(in Chinese)梁明杨，魏垚臣，王一鸣，等．空腹血糖水平与胆石症发病风险的关系[J]．临床肝胆病杂志，2019,35(11):2517-2522.
|
|
[28] FANG BJ,SHEN JY,ZHANG H,et al. Albiflorin Granule significantly decreased the cholesterol gallstone formation by the regulation of insulin transduction signal[J]. Asian Pac J Trop Med,2016,9(9):877-881.
|
|
[29] NESS GC,EDELMAN JL,BROOKS PA. Involvement of tristetraprolin in transcriptional activation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin[J]. Biochem Biophys Res Commun,2012,420(1):178-182.
|
|
[30] DORVASH MR,KHOSHNOOD MJ,SABER H,et al. Metformin treatment prevents gallstone formation but mimics porcelain gallbladder in C57Bl/6 mice[J]. Eur J Pharmacol,2018,833:165-172.
|
|
[31] RAMAKRISHNAN G,ARJUMAN A,SUNEJA S,et al. The association between insulin and low-density lipoprotein receptors[J]. Diab Vasc Dis Res,2012,9(3):196-204.
|
|
[32] DUFER M,HORTH K,KRIPPEIT-DREWS P,et al. The significance of the nuclear farnesoid X receptor(FXR)in beta cell function[J]. Islets,2012,4(5):333-338.
|
|
[33] NOEL OF,STILL CD,ARGYROPOULOS G,et al. Bile acids,FXR,and metabolic effects of bariatric surgery[J]. J Obes,2016,2016:4390254.
|
|
[34] FANG S,SUH JM,REILLY SM,et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance[J]. Nat Med,2015,21(2):159-165.
|
|
[35] LOPEZ-JARAMILLO P,GOMEZ-ARBELAZ D,LOPEZ-LOPEZ J,et al. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes[J]. Horm Mol Biol Clin Investig,2014,18(1):37-45.
|
DownLoad: